BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21969354)

  • 1. Evaluation of mouse tail-vein injections both qualitatively and quantitatively on small-animal PET tail scans.
    Vines DC; Green DE; Kudo G; Keller H
    J Nucl Med Technol; 2011 Dec; 39(4):264-70. PubMed ID: 21969354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
    Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
    Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of 18F-FDG microPET studies in mouse tumor xenografts.
    Dandekar M; Tseng JR; Gambhir SS
    J Nucl Med; 2007 Apr; 48(4):602-7. PubMed ID: 17401098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing experimental protocols for quantitative behavioral imaging with 18F-FDG in rodents.
    Schiffer WK; Mirrione MM; Dewey SL
    J Nucl Med; 2007 Feb; 48(2):277-87. PubMed ID: 17268026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of animal handling on the results of 18F-FDG PET studies in mice.
    Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA
    J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
    Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
    J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution of oral (18)F-FDG for intravenous (18)F-FDG in PET scanning.
    Nair N; Agrawal A; Jaiswar R
    J Nucl Med Technol; 2007 Jun; 35(2):100-4. PubMed ID: 17496005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equal sensitivity of early and late scans after injection of FDG for the detection of Alzheimer pattern: an analysis of 3D PET data from J-ADNI, a multi-center study.
    Takahashi R; Ishii K; Senda M; Ito K; Ishii K; Kato T; Makishi Y; Nishio T; Ikari Y; Iwatsubo T;
    Ann Nucl Med; 2013 Jun; 27(5):452-9. PubMed ID: 23483370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET with 18F-FDG-labeled T lymphocytes for diagnosis of acute rat renal allograft rejection.
    Grabner A; Kentrup D; Edemir B; Sirin Y; Pavenstädt H; Schlatter E; Schober O; Schäfers M; Schnöckel U; Reuter S
    J Nucl Med; 2013 Jul; 54(7):1147-53. PubMed ID: 23670903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
    Chirindel A; Chaudhry M; Blakeley JO; Wahl R
    J Nucl Med; 2015 Mar; 56(3):379-85. PubMed ID: 25655626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-small cell carcinoma: comparison of postoperative intra- and extrathoracic recurrence assessment capability of qualitatively and/or quantitatively assessed FDG-PET/CT and standard radiological examinations.
    Onishi Y; Ohno Y; Koyama H; Nogami M; Takenaka D; Matsumoto K; Yoshikawa T; Matsumoto S; Maniwa Y; Nishimura Y; Sugimura K
    Eur J Radiol; 2011 Sep; 79(3):473-9. PubMed ID: 20547021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproducibility study of [(18)F]FPP(RGD)2 uptake in murine models of human tumor xenografts.
    Chang E; Liu S; Gowrishankar G; Yaghoubi S; Wedgeworth JP; Chin F; Berndorff D; Gekeler V; Gambhir SS; Cheng Z
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):722-30. PubMed ID: 21125268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of 8F-FDG PET/CT in well differentiated thyroid carcinoma with high serum antithyroglobulin antibody.
    Kingpetch K; Pipatrattana R; Tepmongkol S; Sirisalipoch S; Chaiwatanarat T
    J Med Assoc Thai; 2011 Oct; 94(10):1238-44. PubMed ID: 22145510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.
    Kollmannsberger C; Oechsle K; Dohmen BM; Pfannenberg A; Bares R; Claussen CD; Kanz L; Bokemeyer C
    Cancer; 2002 May; 94(9):2353-62. PubMed ID: 12015760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of in vivo brain imaging method in conscious mice.
    Mizuma H; Shukuri M; Hayashi T; Watanabe Y; Onoe H
    J Nucl Med; 2010 Jul; 51(7):1068-75. PubMed ID: 20554730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography.
    Toyama H; Ichise M; Liow JS; Modell KJ; Vines DC; Esaki T; Cook M; Seidel J; Sokoloff L; Green MV; Innis RB
    J Nucl Med; 2004 Aug; 45(8):1398-405. PubMed ID: 15299067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeatable noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG: evaluation of tracer kinetics in a type 1 diabetes model.
    Thorn SL; deKemp RA; Dumouchel T; Klein R; Renaud JM; Wells RG; Gollob MH; Beanlands RS; DaSilva JN
    J Nucl Med; 2013 Sep; 54(9):1637-44. PubMed ID: 23940301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiphase CT scanning and different intravenous contrast media concentrations in combined F-18-FDG PET/CT: Effect on quantitative and clinical assessment.
    Rebière M; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM; Behrendt FF
    Eur J Radiol; 2012 Aug; 81(8):e862-9. PubMed ID: 22591760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer.
    Verburg FA; Kuhl CK; Pietsch H; Palmowski M; Mottaghy FM; Behrendt FF
    Eur J Radiol; 2013 Oct; 82(10):e617-22. PubMed ID: 23880426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.